(Q45471021)

14 December 2017

title

Human immunodeficiency virus type 1 neutralization by plasma from B or F genotype infected individuals (English)

1 reference

14 December 2017

author

Mariza Gonçalves Morgado

6

object named as

Morgado MG

1 reference

14 December 2017

Bongertz V

1

1 reference

14 December 2017

Teixeira SL

2

1 reference

14 December 2017

Grinztejn B

3

1 reference

14 December 2017

Pilotto JH

4

1 reference

14 December 2017

Veloso VG

5

1 reference

14 December 2017

Bastos FI

7

1 reference

14 December 2017

Ouverney EP

8

1 reference

14 December 2017

publication date

1 February 2005

1 reference

Memórias do Instituto Oswaldo Cruz

14 December 2017

published in

1 reference

14 December 2017

volume

100

1 reference

14 December 2017

issue

1

1 reference

14 December 2017

page(s)

85-89

1 reference

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Vertical HIV-1 transmission: importance of neutralizing antibody titer and specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Neutralization titres and vertical HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Is human immunodeficiency virus RNA load composed of neutralized immune complexes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Neutralizing antibodies against HIV -- back in the major leagues?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

The HIV epidemic in the Amazon Basin is driven by prototypic and recombinant HIV-1 subtypes B and F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Neutralizing antibodies mechanism of neutralization and protective activity against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Passive immunization with human neutralizing monoclonal antibodies: correlates of protective immunity against HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Identifying epitopes of HIV-1 that induce protective antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

Anti-HIV-1 seroreactivity and HIV transmission route[R1]

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000100016

10.1590/S0074-02762005000100016

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference